 |
PDBsum entry 1j5h
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
41:11731-11739
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of a novel chromoprotein derived from apo-neocarzinostatin and a synthetic chromophore.
|
|
M.D.Urbaniak,
F.W.Muskett,
M.D.Finucane,
S.Caddick,
D.N.Woolfson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The natural complex Neocarzinostatin comprises a labile chromophore
noncovalently bound to an 11.2 kDa protein. We present the first high-resolution
structure of a novel complex derived from the recombinant apoprotein bound to a
non-natural synthetic chromophore. Fluorescence and nuclear magnetic resonance
spectroscopy were used to probe the strength and location of binding. Binding
occurred in a location similar to that observed for the chromophore in the
natural Neocarzinostatin complex, but with a distinct orientation. These results
provide structural evidence that the apoprotein can readily accommodate small
druglike entities, other than the natural chromophore within its binding cleft.
The clinical use of the natural complex described by others, together with the
results reported here, suggests potential applications for small molecule
binding by apo-Neocarzinostatin.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.W.Chi,
Y.C.Chien,
C.Y.Liu,
C.J.Tseng,
Y.J.Lee,
J.L.Chan,
Y.R.Chu,
and
D.H.Chin
(2011).
Role of steric effects in protein-directed enediyne cycloaromatization of neocarzinostatin.
|
| |
Chemistry,
17,
1493-1506.
|
 |
|
|
|
|
 |
B.Wang,
and
K.M.Merz
(2010).
Importance of loop dynamics in the neocarzinostatin chromophore binding and release mechanisms.
|
| |
Phys Chem Chem Phys,
12,
3443-3449.
|
 |
|
|
|
|
 |
V.T.Hang,
T.J.Oh,
T.Yamaguchi,
and
J.K.Sohng
(2010).
In vivo characterization of NcsB3 to establish the complete biosynthesis of the naphthoic acid moiety of the neocarzinostatin chromophore.
|
| |
FEMS Microbiol Lett,
311,
119-125.
|
 |
|
|
|
|
 |
A.Shanmuganathan,
T.K.Kumar,
C.M.Huang,
C.Yu,
and
D.H.Chin
(2009).
A superior drug carrier--aponeocarzinostatin in partially unfolded state fully protects the labile antitumor enediyne.
|
| |
J Biomed Sci,
16,
48.
|
 |
|
|
|
|
 |
J.Kandaswamy,
P.Hariharan,
T.K.Kumar,
C.Yu,
T.J.Lu,
and
D.H.Chin
(2008).
Is association of labile enediyne chromophore a mutually assured protection for carrier protein?
|
| |
Anal Biochem,
381,
18-26.
|
 |
|
|
|
|
 |
Y.Luo,
S.Lin,
J.Zhang,
H.A.Cooke,
S.D.Bruner,
and
B.Shen
(2008).
Regiospecific O-methylation of naphthoic acids catalyzed by NcsB1, an O-methyltransferase involved in the biosynthesis of the enediyne antitumor antibiotic neocarzinostatin.
|
| |
J Biol Chem,
283,
14694-14702.
|
 |
|
|
|
|
 |
J.R.Baker,
D.N.Woolfson,
F.W.Muskett,
R.G.Stoneman,
M.D.Urbaniak,
and
S.Caddick
(2007).
Protein-small molecule interactions in neocarzinostatin, the prototypical enediyne chromoprotein antibiotic.
|
| |
Chembiochem,
8,
704-717.
|
 |
|
|
|
|
 |
C.G.Sudhahar,
and
D.H.Chin
(2006).
Aponeocarzinostatin--a superior drug carrier exhibiting unusually high endurance against denaturants.
|
| |
Bioorg Med Chem,
14,
3543-3552.
|
 |
|
|
|
|
 |
P.Hariharan,
W.Liang,
S.H.Chou,
and
D.H.Chin
(2006).
A new model for ligand release. Role of side chain in gating the enediyne antibiotic.
|
| |
J Biol Chem,
281,
16025-16033.
|
 |
|
|
|
|
 |
H.Takashima,
T.Yoshida,
T.Ishino,
K.Hasuda,
T.Ohkubo,
and
Y.Kobayashi
(2005).
Solution NMR structure investigation for releasing mechanism of neocarzinostatin chromophore from the holoprotein.
|
| |
J Biol Chem,
280,
11340-11346.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Nicaise,
M.Valerio-Lepiniec,
P.Minard,
and
M.Desmadril
(2004).
Affinity transfer by CDR grafting on a nonimmunoglobulin scaffold.
|
| |
Protein Sci,
13,
1882-1891.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |